You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 6, June 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Evidence-Based Dermatology: Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Evidence-Based Medicine
 •Statistics and Research Methods
 •Review
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Appraising Systematic Reviews and Meta-analyses

Michael Bigby, MD; Hywel Williams, MSc, PhD, FRCP

Arch Dermatol. 2003;139:795-798.

A systematic review is an overview that answers a specific clinical question and contains a thorough, unbiased search of the relevant literature, explicit criteria for assessing studies, and a structured presentation of the results. Many systematic reviews incorporate a meta-analysis, ie, a quantitative pooling of several similar studies to produce an overall summary of treatment effect.1-2 Meta-analysis provides an objective and quantitative summary of evidence that is amenable to statistical analysis,1 and it allows recognition of important treatment effects by combining the results of small trials that individually might have lacked the power to consistently demonstrate differences among treatments. Meta-analysis has been criticized for the discrepancies between its findings and those of large clinical trials.3-6 The frequency of discrepancies ranges from 10% to 23%3 and can often be explained by differences in treatment protocols or study populations or changes that occur over time.3


From the Department of Dermatology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Mass (Dr Bigby); and the Centre of Evidence-Based Dermatology, Queen's Medical Centre, Nottingham, England (Dr Williams). The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does Central Venous Pressure Predict Fluid Responsiveness?: A Systematic Review of the Literature and the Tale of Seven Mares
Marik et al.
Chest 2008;134:172-178.
ABSTRACT | FULL TEXT  

Patient-Care Questions that Physicians Are Unable to Answer
Ely et al.
J. Am. Med. Inform. Assoc. 2007;14:407-414.
ABSTRACT | FULL TEXT  

Tacrolimus and pimecrolimus for atopic dermatitis: where do they fit in?
Bigby
Arch Dermatol 2006;142:1203-1205.
FULL TEXT  

Evaluating Costs for Onychomycosis Treatments: A Practitioner's Perspective
Warshaw
J. Am. Podiatr. Med. Assoc. 2006;96:38-52.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.